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Risk factors for infection and disease in child
contacts of multidrug-resistant tuberculosis: a
cross-sectional study
James A Seddon1,2*, Anneke C Hesseling1, Peter Godfrey-Faussett2, Katherine Fielding3 and H Simon Schaaf1,4
Abstract
Background: Young children exposed to Mycobacterium tuberculosis have a high risk of disease progression
following infection. This study aimed to determine risk factors for M. tuberculosis infection and disease in children
following exposure to adults with multidrug-resistant (MDR) tuberculosis (TB).
Methods: Cross-sectional study; all children aged < 5 years, routinely referred per local guidelines to the provincial
specialist MDR-TB clinic, Western Cape Province, South Africa, following identification as contacts of adult MDR-TB
source cases, were eligible for enrolment from May 2010 through April 2011. Demographic, clinical and social
characteristics were collected. All children underwent HIV and tuberculin skin testing.
Results: Of 228 children enrolled (median age: 30 months), 102 (44.7%) were classified as infected. Of these, 15
(14.7%) had TB disease at enrolment. Of 217 children tested for HIV, 8 (3.7%) were positive. In adjusted analysis,
child’s age (AOR: 1.43; 95% CI: 1.13-1.91; p = 0.002) and previous TB treatment history (AOR: 2.51; 95% CI: 1.22-5.17;
p = 0.01) were independent risk factors for infection. Increasing age of the MDR-TB source case (AOR: 0.67; 95% CI:
0.45-1.00; p = 0.05) was protective and source case alcohol use (AOR: 2.59; 95% CI: 1.29-5.22; p = 0.007) was
associated with increased odds of infection in adjusted analysis. Decreasing age of the child (p = 0.01) and positive
HIV status (AOR: 25.3; 95% CI: 1.63-393; p = 0.01) were associated with prevalent TB disease.
Conclusion: A high proportion of children exposed to MDR-TB are infected or diseased. Early contact tracing might
provide opportunities to prevent the progression to TB disease in children identified as having been exposed to
MDR-TB.
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Background
The development of tuberculosis (TB) requires exposure
to Mycobacterium tuberculosis, subsequent infection, and
finally, progression to disease [1]. The risk of moving from
one state to the next is determined by multiple micro-
biological, immunological, social and cultural factors [1].
The diagnosis of M. tuberculosis infection and disease
in children is challenging as available tests have limitations.
The tuberculin skin test (TST) and commercial interferon-
gamma release assays (IGRAs) have limited sensitivity in
detecting M. tuberculosis infection compared to a reference
standard of either an M. tuberculosis exposure gradient or
confirmed disease [2]. Due to the paucibacillary nature of
pediatric TB, together with challenges in obtaining clinical
samples, microbiologically confirmed TB is obtained in less
than 30% of children with radiological/clinical evidence
of intra-thoracic disease, even when sputum induction
and a referral laboratory are available [3]. The diagnosis
of TB relies on a constellation of history, examination,
immunology, radiology and bacteriology, all with limited
sensitivity and specificity [4]. In the absence of accurate
tests of infection and disease, it is important to understand
the epidemiology of each of the exposure, infection and
disease stages, and risk factors determining progression
* Correspondence: james.seddon@doctors.org.uk
1Desmond Tutu TB Centre, Department of Paediatrics and Child Health,
Faculty of Medicine and Health Sciences, Stellenbosch University, Clinical
Building, Room 0085, P. O. Box 19063, Tygerberg, South Africa
2Department of Clinical Research, Faculty of Infectious and Tropical Diseases,
London School of Hygiene and Tropical Medicine, London, UK
Full list of author information is available at the end of the article
© 2013 Seddon et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Seddon et al. BMC Infectious Diseases 2013, 13:392
http://www.biomedcentral.com/1471-2334/13/392
between each stage. If these factors are identified, inter-
ventions can be targeted to those at the highest risk of
progression to the next stage. As childhood TB results
from recent infection and subsequent disease develop-
ment, children serve as a sentinel marker of ongoing M.
tuberculosis transmission and failing TB control within a
community [5]. Identifying risk factors for infection and
disease in children is therefore important in understanding
the broader epidemic.
For children exposed to drug-susceptible TB, the risk
of becoming infected depends on the infectiousness of
the source case, the intensity and duration of interaction
between the source case and child contact, and the host
immune response [1,6]. The influence of mycobacterial
strain on risk of infection is unclear [7]. Source cases
with extensive lung involvement are more infectious than
those with fewer affected zones on chest radiography
[8-10]. Children in contact with sputum smear-positive
source cases are more likely to become infected than those
in contact with sputum smear-negative disease [10,11],
with greater bacillary loads increasing infectivity [10,12].
Although HIV-positive adults with TB are more likely to
be sputum smear-negative than HIV-negative individuals
[13], it does not appear that they are less infectious
[14,15], possibly indicating HIV-related epidemiological
factors unique to HIV-affected households. Source cases
who live in close physical proximity to child contacts are
more likely to infect children, and the greater the daily
interaction and the longer the duration of interaction, the
greater the risk of infection [16,17]. The duration of cough
in the source case also affects transmission risk [18]. Close
relatives are more likely to infect child contacts than more
distant relatives, and sleeping in the same room increases
infection risk [8-10,16,19-21]. The presence of smokers in
the house has been shown to increase M. tuberculosis
transmission [11,16,22,23], as does crowding [16] and poor
household ventilation [24].
The risk of progression to TB disease in a child
infected with M. tuberculosis is determined by the viru-
lence of the mycobacteria [25], the mycobacterial load
[26], age [27] and host immune response [28]. From
studies prior to the chemotherapy era, it is has been
determined that infected infants (i.e. <12 months) have a
50% life-time risk of progression to disease following
infection, with the risk decreasing with increasing age
[6,27]. Young children also have an increased risk of
severe forms of disease such as miliary TB and TB
meningitis [27]. HIV-positive adults with M. tuberculosis
infection have a 7-10% risk of developing TB each year
in the absence of preventive therapy [29,30]. HIV-positive
infants are more than twenty times as likely to develop TB
as those who are HIV-negative [31] and malnourished
children are more likely to progress to TB than those
better nourished [11].
Although surveillance data are limited, the World Health
Organization (WHO) estimated that there were 650,000
prevalent cases of multidrug-resistant (MDR)-TB world-
wide in 2010 [32]. MDR-TB is defined as M. tuberculosis
resistant to rifampin and isoniazid [33]. A previous MDR-
TB contact study has demonstrated nearly two child
contacts less than five years of age for each MDR-TB
source case in South Africa, a high TB-burden setting
[34], suggesting that large numbers of children are
exposed to MDR-TB in such contexts. Determining
which children are at the highest risk of becoming
infected and of developing disease would allow informed
health planning and targeted use of available healthcare
resources. A cohort study design, where children are
followed from the time of exposure, allows for the
monitoring of transition from exposure to infection,
and from infection to disease, over time. However,
cross-sectional study designs, whereby children are
identified who have exposure but no infection, exposure
and infection and those who present with TB disease, also
allow for an assessment of risk factors for each state.
We aimed to determine risk factors for the transition
from exposure to infection, and from infection to disease
in child MDR-contacts, using a cross-sectional study
design.
Methods
Setting and patient population
The overall TB disease notification rate in the Western
Cape province of South Africa was 976/100,000 in 2009
[35]; with an incidence among children less than 13 years
found to be over 400/100,000 in 2003–2004 [36]. The
annual rate of TB infection among school children in
Cape Town is about 4%, suggesting very high rates of
transmission [37,38]. 8.9% of children with culture-
confirmed TB at one of two regional referral hospitals,
Tygerberg Children’s Hospital (TCH), had MDR-TB
during 2007–2009 [39]. Cape Town is comprised of Black
(mainly of the Xhosa ethnic group), White (mainly of
European ancestry), Indian and Colored (a heterogeneous
ethnic group of mixed ancestry) populations. All children
evaluated at TCH or community outreach specialist
pediatric TB clinics during May 2010 through April
2011, were eligible if they were less than five years old,
had been in significant contact with an infectious (sputum
smear or culture positive) pulmonary MDR-TB source
case within the preceding six months and had an available
TST result. Significant exposure was defined as living with
or having regular daily interaction with the MDR-TB
source case. Children were recruited following written,
informed consent from the parent/caregiver. The study
was approved by the Stellenbosch University and London
School of Hygiene and Tropical Medicine Ethical Com-
mittees, as well as the local health authorities.
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Standard of care
Following the diagnosis of MDR-TB in an adult, contact
tracing was carried out by the local clinic team to iden-
tify vulnerable children. Children exposed to infectious
MDR-TB cases and those with suspected MDR-TB
disease were referred to a specialist pediatric MDR-TB
clinic at TCH or community outreach clinics attended by
the same specialists. HIV testing is routinely performed
following informed consent from the parent or legal
guardian using ELISA in children older than 18 months
or DNA PCR if younger or breast-fed. Combination
antiretroviral therapy (cART) is routinely initiated in all
HIV-positive children following appropriate evaluation.
TST was routinely undertaken by local clinic staff, carried
out by injecting two tuberculin units intradermally
(purified protein derivative RT23, Statens Serum Institute)
with results read at 48–72 hours. All children were
assessed using TB symptom screening, clinical evaluation
and chest radiograph (both antero-posterior and lateral).
Children suspected of having TB disease (clinical or
radiological evidence) underwent microbiological inves-
tigation. Sputum samples, gastric aspirates or biopsies
from extra-pulmonary sites were sent for liquid-based
culture (MGIT 960 system; Becton Dickinson, Sparks,
MD, USA) and drug susceptibility testing (DST) using a
commercial Line Probe Assay (GenoType® MTBDRplus;
Hain Lifescience, Nehren, Germany). They were then
started on a treatment regimen tailored to the DST of
the source case, or, if disease was bacteriologically con-
firmed, that of the child. As per local program guidelines,
children found to have no symptoms, signs or radiology
suggestive of TB disease, were treated with a three-drug
preventive therapy regimen of ofloxacin (15-20 mg/kg),
ethambutol (20-25 mg/kg daily) and high-dose isoniazid
(15-20 mg/kg daily) for six months with regular follow
up for one year to monitor for incident disease [40].
Data collection and classification
This study employed a cross-sectional design. Following
informed consent, families were interviewed by the study
team and data collected regarding the demographic profile
and clinical condition of the child. Information on the
source case was collected both from the attending families
and subsequently from the provincial TB register. The
nature and intensity of the interaction between the
source case and child, as reported by the parent/caregiver,
was documented as well as the duration of exposure.
Children were classified as uninfected or infected, and
if infected, as having TB disease or not. While we
aimed to assess risk factors for prevalent TB disease,
confirmation of diagnosis depended on radiological and
bacteriological investigations, in some instances requiring
a number of weeks for liquid culture results. Standard
research definitions were applied to classify TB disease
[41]; children with either confirmed and probable disease
were included. Infection was classified as having a positive
TST; infection was also assumed in the presence of TB
disease. A transverse TST diameter of ≥10 mm was
considered positive in HIV-negative and ≥5 mm in
HIV-positive children.
Statistical analysis
Data were double-entered into a database and checked
for entry errors. Logistic regression was used to assess
risk factors for (i) M. tuberculosis infection and (ii) TB
disease (among those with infection). Results are
reported as unadjusted and adjusted odds ratios (OR),
95% confidence intervals (CIs) and p-values, calculated
using the likelihood ratio test (LRT). For ordinal variables
a test for trend and departures from linearity using the
LRT was conducted. For models assessing risk factors for
infection, exposures were included if they demonstrated a
relationship with infection in univariable analysis based on
p < 0.05. If two exposures were thought to be co-linear
they were not included together in the same model. For
models assessing risk factors for disease, variables were
only adjusted for the age of the child, given the small
number of children with disease. Ages for the child
and source case were recorded as ordinal variables, using
age bands. Relationships between exposures were assessed
using the χ2 test. All statistical analyses were conducted
using Stata software (version 11; Stata Corp, College Sta-
tion, TX).
Results
Description of cohort
Over the twelve-month study period 377 children were
referred to the specialist clinic services as child contacts
of MDR-TB source cases. A number of children did not
meet the eligibility criteria for the study: the source case
did not have MDR-TB (n = 27), the child was older than
five years (n = 56), the intensity of contact was not
judged to be significant by the clinical team (n = 11) or a
TST result was not available in the presence of an
asymptomatic child (n = 2). Of 281 children eligible for
the study, 228 (81%) were recruited. The remaining 53
children were not brought to the clinic by a parent
or legal guardian who could provide informed consent
(n = 31), the parents did not consent to the study (n = 3)
or the families left the clinic before the research team
could speak to them (n = 19). These children all received
routine standard of care. The median age of children
recruited was 30 months (inter-quartile range [IQR]:
13–43 months); of 217 children tested for HIV, 8 (3.7%)
were positive. Of the 228 children, 102 (44.7%) were
classified as M. tuberculosis-infected. Of the 102 infected,
15 (14.7%) also had TB disease.
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Risk factors for infection
In adjusted analysis, increasing age of the child was asso-
ciated with increasing odds of infection (adjusted odds
ratio (AOR) for one year increase in age: 1.43; 95% CI:
1.13-1.91; p = 0.002); children of Colored ethnicity (com-
pared to children of Xhosa ethnicity) were also more
likely to be infected (AOR: 2.51; 95% CI: 1.22-5.17; p =
0.01). Children with a previous treatment history were
more likely to be infected in univariable analysis, with
the effect reduced after adjustment. See Table 1. Increas-
ing age of the source case was associated with a reduced
odds of infection (AOR: 0.67 for an approximate 10 year
increase in age; 95% CI: 0.45-1.00; p = 0.05) and reported
alcohol use by source case was associated with increased
odds of infection (AOR: 2.59; 95% CI: 1.29-5.22; p =
0.007). Before adjustment there was a strong relation-
ship between HIV status in the source case and M.
tuberculosis infection in the child, with HIV positivity
Table 1 Risk factors for infection in child contacts of multidrug-resistant tuberculosis: child and household
characteristics (n = 228)
Variable Total Infected Unadjusted OR p-value AOR p-value1
(n = 228) (row %) (95% CI) (95% CI)1
(n = 102)
Age of child (n = 224) <1 year 53 15 (28.3) 1 0.05 1.43 (1.13–1.91) 0.0022
1–2 years 36 15 (41.7) 1.81 (0.74–4.42)
2–3 years 51 25 (49.0) 2.44 (1.08–5.48) 0.0072
3–4 years 48 27 (56.3) 3.26 (1.43–7.44)
4–5 years 36 18 (50.0) 2.53 (1.05–6.14)
Gender (n = 227) Female 109 46 (42.2) 1 0.43
Male 118 56 (47.5) 1.24 (0.73–2.09)
Ethnicity Xhosa 101 30 (29.7) 1 <0.001 1 0.01
Colored 125 70 (56.0) 3.01 (1.69–5.36) 2.51 (1.22–5.17)
Previous TB treatment No 207 86 (41.5) 1 0.002 1 0.08
Yes 21 16 (76.2) 4.50 (1.59–12.8) 2.76 (0.84–9.12)
HIV status (n = 217) Negative 209 96 (45.9) 1.0 0.64
Positive 8 3 (37.5) 0.71 (0.16–3.03)
Weight-for-age z-score (n = 218) More than −1 138 60 (43.5) 1 0.14
−1 to −2 47 26 (55.3) 1.61 (0.83–3.13)
Less than −2 33 11 (33.3) 0.65 (0.29–1.44)
BCG scar visible (n = 222) No 40 14 (35.0) 1 0.14
Yes 182 87 (47.8) 1.70 (0.83–3.47)
Type of residence (n = 217) Tin shack 33 8 (24.2) 1 0.007
Brick House 168 79 (47.0) 2.77 (1.18–6.50)
Wendy House 16 11 (68.8) 6.87 (1.83–25.8)
Number of rooms in house 1–2 61 28 (45.9) 1 0.58
3–4 102 42 (41.2) 0.83 (0.44–1.56)
>4 65 32 (49.2) 1.14 (0.57–2.30)
Number of people living in house ≤5 people 109 47 (43.1) 1 0.64
>5 people 119 55 (46.2) 1.13 (0.67–1.91)
Density of people living in house ≤2 people per room 153 72 (47.1) 1 0.31
>2 people per room 75 30 (40.0) 0.75 (0.43–1.31)
Water source (n = 225) Piped water in residence 176 84 (47.7) 1 0.06
Piped water from public source 49 16 (32.7) 0.53 (0.27–1.03)
Toilet Flush toilet in house 163 79 (48.5) 1 0.07
Other 65 23 (35.4) 0.58 (0.32–1.05)
1Adjusted for ethnicity, age of child, previous TB in the child, age of source case, alcohol use in source case and HIV status of source case, 2Test for trend,
AOR adjusted odds ratio, CI confidence interval.
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in the source case associated with lower odds of infection.
In multivariable analysis this association was reduced
(AOR 0.48, 95% CI 0.22-1.04; p = 0.06). See Table 2.
Risk factors for prevalent TB disease
Younger age of the child was associated with increased
odds of disease (p-value for test of trend; p = 0.01) as
was HIV-positive status in the child (AOR: 25.3; 95% CI:
1.63-393; p = 0.01), HIV positivity of the source case
(AOR: 4.07; 95% CI: 1.19-13.8; p = 0.03), increasing num-
ber of rooms in the house (AOR: 1.39; 1.02-1.91; p = 0.04)
and alcohol use by the source case (AOR 2.90; 95% CI
0.90-9.31; p = 0.07). Male gender (AOR: 0.29; 95% CI:
0.08-1.00; p = 0.04) was associated with reduced odds of
disease. See Tables 3 and 4.
Relationships between exposures
HIV positivity in the source case was associated with
HIV-positive status in the child (p = 0.019), but also with
ethnicity (p < 0.001), and with the age of the source case
(p-value for test of trend = 0.003). Ethnicity of the child
was associated with type of residence (p < 0.001), type of
water source (p < 0.001) and type of toileting (p < 0.001).
The age of the source case was associated with sputum
smear status (p = 0.001), with older source cases less
likely to have sputum smear-positive TB.
Discussion
This is the first study, to our knowledge, to assess risk
factors for M. tuberculosis infection and disease in chil-
dren exposed to an adult with MDR-TB. Consistent with
data from the natural history of drug-susceptible TB in
children, we demonstrate that as children become older,
they are more likely to be infected but once infected,
that younger children are more likely to develop disease.
We also show that HIV-positive children, while having
no additional risk of M. tuberculosis infection, have a
substantially increased risk for disease following infec-
tion. The proportion of children who were HIV-positive
in our study was relatively low consistent with ongoing
household studies of drug-susceptible disease in the same
communities (personal communication: Anneke Hesseling)
and published household contact investigations undertaken
previously in this setting [7]. This likely reflects effective
prevention of mother-to-child HIV transmission programs
in the Western Cape. Alcohol use in the source case
appears to be a risk factor for infection in the child and
possibly for disease. The relationship between ethnicity,
HIV positivity, age and sputum-smear status of the source
case is complex. In our study, older source cases were
more likely to be HIV-positive and ethnicity was strongly
associated with HIV positivity. Other studies have demon-
strated that HIV-positive adults with pulmonary TB are
less frequently smear-positive than HIV-negative adults
[42]. The increased risk of TB disease in child contacts
of HIV-positive source cases may be due to biological
(e.g. increased risk of HIV positivity) and epidemiological
factors in HIV-affected households.
Previous studies have demonstrated that as children
get older they are more likely to become infected, likely
due to increasing duration of exposure to more potential
source cases and more interaction with the community
in addition to household exposure [9]. The relationship
between alcohol use in the source case and both infection
and disease in the child requires further study. It may
be that alcohol is a surrogate for other socioeconomic
factors but alcohol was not associated with ethnicity or
any of the other socioeconomic exposures recorded in
our study. It may be that source cases that drink are in
some way more infectious than those who do not drink
or that their behavior is more likely to lead to infection
(e.g. prolonged exposure due to diagnostic and treatment
delay) in the child [43]. Adherence to treatment may be
affected as might health-seeking behavior. Alcohol is a
demonstrated risk factor for TB disease in adults with
drug-susceptible [44] and MDR-TB [45]. That HIV posi-
tivity [31] and younger age [27] of the child is associated
with increased risk of progression to disease, following
infection, is well described in the drug-susceptible TB
literature, and we have demonstrated that it also appears
to be true for children exposed to MDR-TB. The propor-
tion of children with disease is consistent with other
household contact studies from this setting [7]. The asso-
ciation between gender of the child and disease also
requires further examination. It is possible that girls are
more likely to progress to disease or this association
may reflect some sociological or cultural attitude to
child-rearing or health-seeking behavior. Houses with
more rooms may be a surrogate for socioeconomic sta-
tus, TB transmission, lifestyle, behavior or nutrition. It
may be that multiple families live in houses with more
rooms, whereas buildings with fewer rooms only house
one family.
A limitation of our study is the relatively small number
of children included, and the small number of children
with disease. This may have concealed associations that
may have been evident if larger numbers had been
included. In previous drug-susceptible childhood contact
studies, measures of intensity (e.g. proximity of sleeping)
and duration of exposure demonstrated a graded relation-
ship with risk of infection in the child, as did the infec-
tiousness of the source case [9,46]. We were unable to
show such relationships. We also did not compare
children exposed to MDR-TB with children exposed to
drug-susceptible TB to determine if systematic differences
between the two populations exist (e.g. in child and source
case demographics or risk factors for infection and
disease). It is possible that MDR-TB in the source case,
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Table 2 Risk factors for infection in child contacts of multidrug-resistant tuberculosis: source case and exposure
characteristics (n = 228)
Variable Total Infected OR p-value AOR p-value1
(n = 228) (row %) (95% CI) (95% CI)1
(n = 102)
Age of source case (n = 219) 16–25 55 31 (56.4) 1 0.06 0.67 (0.45–1.00) 0.052
26–35 86 40 (46.5) 0.67 (0.34–1.33) 0.022
>35 78 28 (35.9) 0.43 (0.21–0.88)
Gender of source case (n = 226) Female 138 62 (44.9) 1 0.93
Male 88 39 (43.3) 0.98 (0.57–1.67)
Smoking status of source case (n = 225) Non-smoker 130 52 (40.0) 1 0.09
Smoker 95 49 (51.6) 1.60 (0.94–2.73)
Alcohol use by source case (n = 225)3 Never drinks 166 65 (39.2) 1 0.004 1 0.007
Drinks alcohol 59 36 (61.0) 2.43 (1.32–4.47) 2.59 (1.29–5.22)
Smear result of source case (n = 224) Negative 28 9 (32.1) 1 0.17
Positive 196 90 (45.9) 1.79 (0.77–4.16)
Smear grade of source case (n = 217) Negative 28 9 (32.1) 1 0.13
Scanty 18 8 (44.4) 1.69 (0.50–5.73)
1+ 28 15 (53.6) 2.44 (0.82–7.22)
2+ 107 44 (41.1) 1.47 (0.61–3.56)
3+ 36 22 (61.1) 3.31 (1.17–9.37)
HIV status of source case (n = 224) Negative 150 79 (52.7) 1 <0.001 1 0.06
Positive 74 20 (27.0) 0.33 (0.18–0.61) 0.48 (0.22–1.04)
CD4 count of source case if HIV-positive
(n = 71)
<200 33 7 (21.2) 1 0.46
>200 38 11 (28.9) 1.51 (0.50–4.56)
Relationship of source case to child Parents 100 38 (38.0) 1 0.34
Grandparent 31 15 (48.4) 1.53 (0.68–3.45)
Uncle or aunt 66 33 (50.0) 1.63 (0.87–3.06)
Other 31 16 (51.6) 1.74 (0.77–3.92)
Duration of exposure between source case
and child
Less than a month 30 13 (43.3) 1 0.62
One month to six
months
92 38 (41.3) 0.92 (0.40–2.11)
More than six
months
106 51 (48.1) 1.21 (0.54–2.74)
Primary caregiver to child Index case 55 21 (38.2) 1 0.26
Not index case 173 81 (46.8) 1.43 (0.77–2.65)
Frequency of contact between source case
and child
Daily 213 93 (43.7) 1 0.23
Less frequently 15 9 (60.0) 1.94 (0.67–5.63)
Intensity of contact between child and
source case
Sleeps in the same
bed
57 25 (43.9) 1 0.67
Sleeps in the same
room
34 13 (38.2) 0.79 (0.33–1.89)
Sleeps in the same
house
101 45 (44.6) 1.03 (0.53–1.98)
Sleeps in a different
house
36 19 (52.8) 1.43 (0.62–3.31)
1Adjusted for ethnicity, age of child, previous TB in the child, age of source case, alcohol use in source case and HIV status of source case, 2Test of trend, 3Regular
alcohol use in source case as reported by the parent or legal guardian of the child, AOR adjusted odds ratio, CI confidence interval.
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where typically long exposure durations are seen due to
previous failed first-line treatments, may potentially ob-
scure the relationship between risk factors and infection.
It would also have been useful to compare MDR-TB-ex-
posed children with community controls without a known
source case to document the background (i.e. community,
presumably drug-susceptible) infection rate. A further
limitation is the study design; although risk factors for the
different states (exposure, infection and disease) were eval-
uated, it was not possible to determine whether the child
or the identified source case acquired the infection/disease
first. Finally, the definition of infection in our study was
one TST measurement undertaken at the initial evalu-
ation. Not only is TST an imperfect measure of infection,
but we also did not complete TST retesting at follow-up
visits in this cross-sectional study.
Table 3 Risk factors for disease in child contacts of multidrug-resistant tuberculosis: child and household
characteristics (n = 102)
Variable Total Disease OR p-value Age-adjusted OR p-value
(n = 102) (row %) (95% CI) (95% CI)
(n = 15)
Age (n = 100) <1 year 15 4 (26.7) 1 0.28 n/a n/a
1–2 years 15 3 (20.0) 0.69 (0.12–3.79)
2–3 years 25 6 (24.0) 0.87 (0.20–3.77)
3–4 years 27 2 (7.4) 0.22 (0.03–1.38) 0.011
4–5 years 18 0 (0) -
Gender Female 46 11 (23.9) 1 0.02 1 0.04
Male 56 4 (7.1) 0.24 (0.72–0.83) 0.29 (0.08–1.00)
Ethnicity Xhosa 30 7 (23.3) 1 0.13
Colored 70 8 (11.4) 0.42 (0.14–1.33)
Previous TB treatment No 86 14 (16.3) 1 0.32
Yes 16 1 (6.3) 0.34 (0.04–2.81)
HIV status (n = 99) Negative 96 13 (13.5) 1 0.04 1 0.01
Positive 3 2 (66.7) 12.8 (1.07–151.1) 25.3 (1.63–393)
Weight-for-age z-score (n = 97) More than −1 60 10 (16.7) 1 0.19
−1 to −2 26 1 (3.8) 0.20 (0.02–1.65)
Less than −2 11 1 (9.1) 0.50 (0.06–4.45)
BCG scar visible (n = 101) No 14 2 (14.3) 1 0.95
Yes 87 13 (14.9) 1.05 (0.21–5.27)
Type of residence (n = 98) Tin shack 8 1 (12.5) 1 0.84
Brick house 79 12 (15.2) 1.25 (0.14–11.1)
Wendy house 11 1 (9.1) 0.70 (0.04–13.2)
Number of rooms in house 1-2 28 2 (7.1) 0.04 1.39 (1.02–1.91) 0.041
3-4 42 4 (9.5) 1.37 (0.23–8.03)
>4 32 9 (28.1) 5.09 (1.00–26.0) 0.021
Number of people living in house ≤5 people 47 5 (10.6) 1 0.29
>5 people 55 10 (18.2) 1.87 (0.59–5.91)
Density of people living in house ≤2 people per room 72 12 (16.7) 1 0.39
>2 people per room 30 3 (10) 0.56 (0.14–2.16)
Water source (n = 100) House tap 84 12 (14.3) 1 0.65
No house tap 16 3 (18.8) 1.38 (0.34–5.60)
Toilet Flush toilet in house 79 12 (15.2) 1 0.80
Other 23 3 (13.0) 0.84 (0.21–3.26)
1Test of trend, OR odds ratio, CI confidence interval.
Seddon et al. BMC Infectious Diseases 2013, 13:392 Page 7 of 10
http://www.biomedcentral.com/1471-2334/13/392
Table 4 Risk factors for disease in child contacts of multidrug-resistant tuberculosis: source case and exposure
characteristics (n = 102)
Variable Total Disease OR p-value Age-adjusted OR p-value
(n = 102) (row %) (95% CI) (95%CI)
(n = 15)
Age of source case (n = 99) 16–25 31 4 (12.9) 1 0.81
26–35 40 5 (12.5) 0.96 (0.24–3.94)
>35 28 5 (17.9) 1.47 (0.35–6.12)
Gender of source case (n = 101) Female 62 11 (17.7) 1 0.31
Male 39 4 (10.3) 0.53 (0.16–1.80)
Smoking status of source case (n = 101) Non-smoker 52 8 (15.4) 1 0.88
Smoker 49 7 (14.3) 0.92 (0.31–2.75)
Alcohol use by source case (n = 101)1 Never drinks 65 6 (9.2) 1 0.04 1 0.07
Drinks alcohol 36 9 (25.0) 3.28 (1.06–10.1) 2.90 (0.90–9.31)
Smear result of source case (n = 99) Negative 9 0 (0) - 0.35
Positive 90 15 (16.7) -
Smear grade of source case (n = 98) Negative 9 0 (0) - 0.05
Scanty 8 0 (0) -
1+ 15 5 (33.3) -
2+ 44 9 (20.5) -
3+ 22 1 (4.5) -
HIV status of source case (n = 99) Negative 79 8 (10.1) 1 0.009 1 0.03
Positive 20 7 (35.0) 4.78 (1.45–15.5) 4.07 (1.19–13.8)
CD4 count of source case if HIV-positive
(n = 18)
<200 7 3 (42.9) 1 0.78
>200 11 4 (36.4) 0.76 (0.11–5.28)
Relationship of source case to child Parents 38 5 (13.2) 1 0.62
Grandparent 15 4 (26.7) 2.4 (0.55–10.6)
Uncle or aunt 33 4 (12.1) 0.91 (0.22–3.71)
Other 16 2 (12.5) 0.94 (0.16–5.45)
Duration of exposure between source
case and child
Less than a month 13 3 (23.1) 1 0.35
One month to six
months
38 7 (18.4) 0.75 (0.16–3.47)
More than six
months
51 5 (9.8) 0.36 (0.07–1.77)
Primary caregiver to child Index case 21 2 (9.5) 1 0.46
Not index case 81 13 (16.0) 1.82 (0.38–8.76)
Frequency of contact between source
case and child
Daily 93 12 (12.9) 1 0.12
Less frequently 9 3 (33.3) 3.38 (0.74–15.3)
Intensity of contact between child and
source case
Sleeps in the same
bed
25 3 (12.0) 1 0.47
Sleeps in the same
room
13 1 (7.7) 0.61 (0.06–6.54)
Sleeps in the same
house
45 6 (13.3) 1.13 (0.26–4.96)
Sleeps in a different
house
19 5 (26.3) 2.62 (0.54–12.7)
1Regular alcohol use in source case as reported by the parent or legal guardian of the child, OR odds ratio, CI confidence interval.
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Conclusions
Our study has several implications. Ongoing vigilance
should be used in the clinical evaluation of child house-
hold contacts, particularly very young (less than three
years) or HIV-positive children, following exposure to an
MDR-TB source case, based on the high risk of disease
progression. In the light of the high demonstrated risk
of M. tuberculosis infection and of disease progression,
the need for contact investigations following an MDR-
TB diagnosis in the source case is emphasized, as is the
need to carry out these investigations rapidly so that
children are identified before they have progressed to
disease. Alcohol dependency programs must be integrated
into MDR-TB programs given the close relationship
between the two epidemics. Finally, the implications of
ethnicity and socioeconomic factors on the risk of infec-
tion and disease in children require further evaluation.
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